A natural product inhibits the initiation of α-synuclein aggregation and suppresses its toxicity
Open accessThe DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Significance: Parkinson’s disease is characterized by the presence in brain tissues of aberrant aggregates primarily formed by the protein α-synuclein. It has been difficult, however, to identify compounds capable of preventing the formation of such deposits because of the complexity of the aggregation process of α-synuclein. By exploiting recently developed highly quantitative in vitro assays, we identify a compound, squalamine, that blocks α-synuclein aggregation, and characterize its mode of action. Our results show that squalamine, by competing with α-synuclein for binding lipid membranes, specifically inhibits the initiation of the aggregation process of α-synuclein and abolishes the toxicity of α-synuclein oligomers in neuronal cells and in an animal model of Parkinson’s disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
THE GENETICS OF CAENORHABDITIS ELEGANS
Brenner, S. (1974) · Genetics · doi:10.1093/genetics/77.1.71 · Cited by 15,081
Protein Misfolding, Functional Amyloid, and Human Disease
Chiti, F., & Dobson, C. M. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.101304.123901 · Cited by 6,423
Self-citationC. elegans: des neurones et des gènes
Gally, C., & Bessereau, J.-L. (2003) · médecine/sciences · doi:10.1051/medsci/20031967725 · Cited by 3,287
Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M., & Goedert, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6469 · Cited by 2,868
The amyloid state and its association with protein misfolding diseases.
Knowles, T. P. J., Vendruscolo, M., & Dobson, C. M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3810 · Cited by 2,382
Self-citationMolecular anatomy of a trafficking organelle
Takamori, S., Holt, M., Stenius, K., Lemke, E. A., Grønborg, M., Riedel, D., Urlaub, H., Schenck, S., Brügger, B., Ringler, P., et al. (2006) · Cell · doi:10.1016/j.cell.2006.10.030 · Cited by 2,373
Molecular Pathways of Neurodegeneration in Parkinson's Disease
Dawson, T. M., & Dawson, V. L. (2003) · Science · doi:10.1126/science.1087753 · Cited by 1,663
Unfolding the role of protein misfolding in neurodegenerative diseases
Soto, C. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1007 · Cited by 1,506 · cited 2×
“Proc Natl Acad Sci USA 108(38):15978–15983.”
MethodProliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism
Cohen, S. I. A., Linse, S., Luheshi, L. M., Hellstrand, E., White, D. A., Rajah, L., Otzen, D. E., Vendruscolo, M., Dobson, C. M., & Knowles, T. P. J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1218402110 · Cited by 1,440
Self-citationAnderson, J. P., Walker, D. E., Goldstein, J. M., de Laat, R., Banducci, K., Caccavello, R. J., Barbour, R., Huang, J., Kling, K., Lee, M., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600933200 · Cited by 1,416
Membrane Phosphatidylserine Regulates Surface Charge and Protein Localization
Yeung, T., Gilbert, G. E., Shi, J., Silvius, J., Kapus, A., & Grinstein, S. (2008) · Science · doi:10.1126/science.1152066 · Cited by 1,107
Eliezer, D., Kutluay, E., Bussell, R., & Browne, G. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4538 · Cited by 1,090
Direct Observation of the Interconversion of Normal and Toxic Forms of α-Synuclein
Cremades, N., Cohen, S. I. A., Deas, E., Abramov, A. Y., Chen, A. Y., Orte, A., Sandal, M., Clarke, R. W., Dunne, P., Aprile, F. A., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.037 · Cited by 911
Self-citationOpposing activities protect against age-onset proteotoxicity
Cohen, E., Bieschke, J., Perciavalle, R. M., Kelly, J. W., & Dillin, A. (2006) · Science · doi:10.1126/science.1124646 · Cited by 843
Composition of isolated synaptic boutons reveals the amounts of vesicle trafficking proteins
Wilhelm, B. G., Mandad, S., Truckenbrodt, S., Kröhnert, K., Schäfer, C., Rammner, B., Koo, S. J., Claßen, G. A., Krauss, M., Haucke, V., et al. (2014) · Science · doi:10.1126/science.1252884 · Cited by 770
Scherzinger, E., Sittler, A., Schweiger, K., Heiser, V., Lurz, R., Hasenbank, R., Bates, G. P., Lehrach, H., & Wanker, E. E. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.8.4604 · Cited by 705
Expression of human beta-amyloid peptide in transgenic Caenorhabditis elegans.
Link, C. D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9368 · Cited by 687
Buell, A. K., Galvagnion, C., Gaspar, R., Sparr, E., Vendruscolo, M., Knowles, T. P. J., Linse, S., & Dobson, C. M. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1315346111 · Cited by 664
Self-citationLipid vesicles trigger α-synuclein aggregation by stimulating primary nucleation
Galvagnion, C., Buell, A. K., Meisl, G., Michaels, T. C. T., Vendruscolo, M., Knowles, T. P. J., & Dobson, C. M. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1750 · Cited by 661 · cited 10×
“In particular, it is well established that phospholipid binding can accelerate fibril formation (11); moreover, it has recently been shown that such acceleration occurs through the enhancement of the initial primary nucleation step in the aggregation process (12).”
BackgroundMethodInfluentialSelf-citationα-Synuclein misfolding and Parkinson's disease
Breydo, L., Wu, J. W., & Uversky, V. N. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.10.002 · Cited by 657
Dependence of α-Synuclein Aggregate Morphology on Solution Conditions
Hoyer, W., Antony, T., Cherny, D., Heim, G., Jovin, T. M., & Subramaniam, V. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00775-1 · Cited by 565
Direct observation of the three regions in α-synuclein that determine its membrane-bound behaviour
Fusco, G., De Simone, A., Gopinath, T., Vostrikov, V., Vendruscolo, M., Dobson, C. M., & Veglia, G. (2014) · Nature Communications · doi:10.1038/ncomms4827 · Cited by 528
Self-citationThe Aggregation and Fibrillation of α-Synuclein
Fink, A. L. (2006) · Accounts of Chemical Research · doi:10.1021/ar050073t · Cited by 501
Mechanisms of Parkinson's Disease Linked to Pathological α-Synuclein: New Targets for Drug Discovery
Lee, V. M.-Y., & Trojanowski, J. Q. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.026 · Cited by 479
Chen, S. W., Drakulic, S., Deas, E., Ouberai, M., Aprile, F. A., Arranz, R., Ness, S., Roodveldt, C., Guilliams, T., De-Genst, E. J., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1421204112 · Cited by 460
Self-citationC. elegans Model Identifies Genetic Modifiers of α-Synuclein Inclusion Formation During Aging
van Ham, T. J., Thijssen, K. L., Breitling, R., Hofstra, R. M. W., Plasterk, R. H. A., & Nollen, E. A. A. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000027 · Cited by 427
Self-citationSqualamine: an aminosterol antibiotic from the shark.
Moore, K. S., Wehrli, S., Roder, H., Rogers, M., Forrest, J. N., McCrimmon, D., & Zasloff, M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.4.1354 · Cited by 423
Self-citationA Role for SIR-2.1 Regulation of ER Stress Response Genes in Determining C. elegans Life Span
Viswanathan, M., Kim, S. K., Berdichevsky, A., & Guarente, L. (2005) · Developmental Cell · doi:10.1016/j.devcel.2005.09.017 · Cited by 409
Multiple Tight Phospholipid-Binding Modes of α-Synuclein Revealed by Solution NMR Spectroscopy
Bodner, C. R., Dobson, C. M., & Bax, A. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.05.066 · Cited by 376
Self-citationFlagmeier, P., Meisl, G., Vendruscolo, M., Knowles, T. P. J., Dobson, C. M., Buell, A. K., & Galvagnion, C. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1604645113 · Cited by 333
Self-citationNMR of α‐synuclein–polyamine complexes elucidates the mechanism and kinetics of induced aggregation
Fernández, C. O., Hoyer, W., Zweckstetter, M., Jares‐Erijman, E. A., Subramaniam, V., Griesinger, C., & Jovin, T. M. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600211 · Cited by 255
Martí-Massó, J. F., & Martínez, J. R. (2000) · PubMed · Cited by 231
Impact of N-Terminal Acetylation of α-Synuclein on Its Random Coil and Lipid Binding Properties
Maltsev, A. S., Ying, J., & Bax, A. (2012) · Biochemistry · doi:10.1021/bi300642h · Cited by 219
Self-citationHabchi, J., Arosio, P., Perni, M., Costa, A. R., Yagi-Utsumi, M., Joshi, P., Chia, S., Cohen, S. I. A., Müller, M. B. D., Linse, S., et al. (2016) · Science Advances · doi:10.1126/sciadv.1501244 · Cited by 208
Self-citationvan der Goot, A. T., Zhu, W., Vázquez-Manrique, R. P., Seinstra, R. I., Dettmer, K., Michels, H., Farina, F., Krijnen, J., Melki, R., Buijsman, R. C., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1203083109 · Cited by 194
Self-citationGidalevitz, T., Krupinski, T., Garcia, S., & Morimoto, R. I. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000399 · Cited by 192
TARP Phosphorylation Regulates Synaptic AMPA Receptors through Lipid Bilayers
Sumioka, A., Yan, D., & Tomita, S. (2010) · Neuron · doi:10.1016/j.neuron.2010.04.035 · Cited by 167
Bartels, T., Kim, N. C., Luth, E. S., & Selkoe, D. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103727 · Cited by 164
Tóth, G., Gardai, S. J., Zago, W., Bertoncini, C. W., Cremades, N., Roy, S. L., Tambe, M. A., Rochet, J.-C., Galvagnion, C., Skibinski, G., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087133 · Cited by 151 · cited 3×
“Biochim Biophys Acta 1832(8):1217–1226.”
BackgroundSelf-citationEffects of Parkinson's Disease-Linked Mutations on the Structure of Lipid-Associated α-Synuclein
Bussell, R., & Eliezer, D. (2004) · Biochemistry · doi:10.1021/bi036135+ · Cited by 147
Targeted Amino-Terminal Acetylation of Recombinant Proteins in E. coli
Johnson, M., Coulton, A. T., Geeves, M. A., & Mulvihill, D. P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015801 · Cited by 144
Identification of MOAG-4/SERF as a regulator of age-related proteotoxicity
van Ham, T. J., Holmberg, M. A., van der Goot, A. T., Teuling, E., Garcia-Arencibia, M., Kim, H.-E., Du, D., Thijssen, K. L., Wiersma, M., Burggraaff, R., et al. (2010) · Cell · doi:10.1016/j.cell.2010.07.020 · Cited by 133
Self-citationKeeping track of worm trackers
Husson, S. J. (2012) · WormBook · doi:10.1895/wormbook.1.156.1 · Cited by 132
Evangelisti, E., Cascella, R., Becatti, M., Marrazza, G., Dobson, C. M., Chiti, F., Stefani, M., & Cecchi, C. (2016) · Scientific Reports · doi:10.1038/srep32721 · Cited by 132
Self-citationSqualamine as a broad-spectrum systemic antiviral agent with therapeutic potential
ZASLOFF, M. A., Adams, A. P., Beckerman, B., Campbell, A. E., Han, Z., Luijten, E., Meza, I., Julander, J. G., Mishra, A., Qu, W., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108558108 · Cited by 123
Self-citationNew insights into cellular α-synuclein homeostasis in health and disease
Dettmer, U., Selkoe, D. J., & Bartels, T. (2015) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2015.07.007 · Cited by 104
Brown, J. W., Buell, A. K., Michaels, T. C. T., Meisl, G., Carozza, J. A., Flagmeier, P., Vendruscolo, M., Knowles, T. P. J., Dobson, C. M., & Galvagnion, C. (2016) · Scientific Reports · doi:10.1038/srep36010 · Cited by 91
Self-citationLi, D., Williams, J. I., & Pietras, R. J. (2002) · Oncogene · doi:10.1038/sj.onc.1205410 · Cited by 89
Detergent-like Interaction of Congo Red with the Amyloid β Peptide
Lendel, C., Bolognesi, B., Wahlström, A., Dobson, C. M., & Gräslund, A. (2010) · Biochemistry · doi:10.1021/bi902005t · Cited by 79
Self-citationExtracellular chaperones prevent Aβ42-induced toxicity in rat brains
Cascella, R., Conti, S., Tatini, F., Evangelisti, E., Scartabelli, T., Casamenti, F., Wilson, M. R., Chiti, F., & Cecchi, C. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.04.012 · Cited by 79
Self-citationKosten, J., Binolfi, A., Stuiver, M., Verzini, S., Theillet, F., Bekei, B., van Rossum, M., & Selenko, P. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn5002254 · Cited by 72
Membrane surface charge dictates the structure and function of the epithelial Na+/H+ exchanger
Alexander, R. T., Jaumouillé, V., Yeung, T., Furuya, W., Peltekova, I. T., Boucher, A., ZASLOFF, M. A., Orlowski, J., & Grinstein, S. (2011) · The EMBO Journal · doi:10.1038/emboj.2010.356 · Cited by 62
Self-citationGómez‐Tortosa, E., Ingraham, A. O., Irizarry, M. C., & Hyman, B. T. (1998) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1998.tb06016.x · Cited by 50
EFFECT OF SQUALAMINE ON IRIS NEOVASCULARIZATION IN MONKEYS
Genaidy, M. M., Kazi, A. A., Peyman, G. A., Passos, E., Farahat, H. G., Williams, J. I., Holroyd, K. J., & Blake, D. A. (2002) · Retina · doi:10.1097/00006982-200212000-00014 · Cited by 41
Cited by
Nguyen, P. H., Ramamoorthy, A., Sahoo, B. R., Zheng, J., Faller, P., Straub, J. E., Dominguez, L., Shea, J.-E., Dokholyan, N. V., De Simone, A., et al. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01122 · Cited by 678
Parkinson’s Disease: Biomarkers, Treatment, and Risk Factors
Emamzadeh, F. N., & Surguchov, A. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00612 · Cited by 568
Carroll, A. R., Copp, B. R., Davis, R. A., Keyzers, R. A., & Prinsep, M. R. (2019) · Natural Product Reports · doi:10.1039/c8np00092a · Cited by 518
Lang, A. E., & Espay, A. J. (2018) · Movement Disorders · doi:10.1002/mds.27360 · Cited by 370
Emerging therapies in Parkinson disease — repurposed drugs and new approaches
Elkouzi, A., Vedam-Mai, V., Eisinger, R. S., & Okun, M. S. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0155-7 · Cited by 300
Metadata
- Authors
- Perni, M., Galvagnion, C., Maltsev, A., Meisl, G., Müller, M. B. D., Challa, P. K., Kirkegaard, J. B., Flagmeier, P., Cohen, S. I. A., Cascella, R., Chen, S. W., Limbocker, R., Sormanni, P., Heller, G. T., Aprile, F. A., Cremades, N., Cecchi, C., Chiti, F., Nollen, E. A. A., Knowles, T. P. J., Vendruscolo, M., Bax, A., Zasloff, M., & Dobson, C. M.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2017-01-17
- Volume
- 114
- Issue
- 6
- Pages
- E1009-E1017
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2571594992
- Cited by
- 298
- References
- 54
- FWCI
- 20.34
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.